Across TCGA pan-cancer cohorts, RNY4P14 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RNY4P14’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where RNY4P14 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNY4P14 is over-expressed in tumor.

BRCA and STAD are the cancer types where RNY4P14 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNY4P14 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	II,III,IV	+0.157	.007	4	view →
STAD	Male	All	+0.146	.042	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: RNY4P14 RNA expression & survival · all RNY4P14 data types